Several observational studies support the hypothesis that statin use reduces the risk of advanced prostate cancer. In this Review, the authors discuss molecular mechanisms that might determine this effect, as well as data from clinical studies on associations between statin use and various prostate cancer outcomes, highlighting areas that require further research.
- Mahmoud A. Alfaqih
- Emma H. Allott
- Stephen J. Freedland